Primary prevention of dementia
Symptomatic treatments that work by enhancing neurotransmitter function have been available for several years, and are generally accepted as being modestly beneficial in about 50% of those for whom they are prescribed. Disease-modifying drugs that may prevent or retard neuronal deterioration are bei...
Автор: | Wilcock, G |
---|---|
Формат: | Book section |
Опубліковано: |
2004
|
Схожі ресурси
-
Methodological issues in primary prevention trials for neurodegenerative dementia.
за авторством: Andrieu, S, та інші
Опубліковано: (2009) -
Dementia with Lewy bodies.
за авторством: Wilcock, G
Опубліковано: (2003) -
The ageing brain and dementia.
за авторством: Wilcock, G
Опубліковано: (1981) -
Memantine for the treatment of dementia.
за авторством: Wilcock, G
Опубліковано: (2003) -
A review of dementia.
за авторством: Wilcock, G
Опубліковано: (1982)